The global insufflation devices market was valued at USD 2.98 Billion in 2025, driven by the increasing prevalence of chronic diseases and technological advancements across the globe. The market is anticipated to grow at a CAGR of 6.40% during the forecast period of 2026-2035, with the values likely to reach USD 5.54 Billion by 2035.
Base Year
Historical Period
Forecast Period
One of the major market trends include rising approvals from regulatory authorities to boost innovation. For instance, in January 2023, Palliare announced that the U.S. FDA granted a 510(k) expanded indication for its EVA15 insufflation technology, allowing it to accommodate a higher pressure range. This advancement enhances its role in minimally invasive surgeries.
The market is experiencing a shift towards single-use and gasless insufflation systems, digital integration for better control, and a growing preference for disposable devices, all of which are intended for better surgical outcomes, efficiency, and patient safety.
Leading players in the market are focusing on enhancing device functionality and expanding their global footprint. These companies are addressing the growing demand for advanced insufflation solutions while ensuring improved safety and surgical efficiency.
Insufflation devices are used to introduce a gas, usually carbon dioxide (CO2), into the body during surgical procedures. These devices help in expanding the area of interest, thereby creating more space for surgeons to operate in minimally invasive surgeries such as laparoscopy. These devices are critical in improving visibility, reducing the need for large incisions, and enhancing patient recovery times. The market is showing significant growth as the patient population is shifting towards less invasive surgeries and technical advancements in the devices. The market is expected to grow as surgical techniques evolve and demand for faster recovery times rises.
Increasing Prevalence of Chronic Diseases to Elevate the Market Growth
The rising incidence of chronic diseases like obesity, cardiovascular diseases, and cancer is driving the market for insufflation devices. According to the Centers for Disease Control and Prevention, an estimated 129 million people have at least one major chronic disease in the United States. These conditions require extensive surgeries and during such procedures, insufflation devices help provide the surgeons with the appropriate space to operate. With increasing surgical requirements, the market is expected to witness significant growth in the forecast period.
Technological Advancements to Augment the Insufflation Devices Market Value
Continuous technological innovation in the field of insufflation devices is impacting the market demand significantly. Advanced digital control systems, accurate pressure monitoring, and better gas delivery systems are leading to an increased adoption of insufflation devices. These features improve accuracy, safety, and comfort for patients in surgical procedures. With new technologies being implemented into insufflation devices, healthcare service providers are now increasingly adopting them, thus causing market growth.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
Segmentation Based on Application to Witness Substantial Growth
Based on application, the market is categorized into laparoscopic surgery, bariatric surgery, cardiac surgery, endoscopic, and others. Laparoscopic surgery is likely to hold a significant share in the market. It is a minimally invasive process, which reduces the size of incisions and results in fast recovery times, thereby making it a popular practice for abdominal, gynecological, and urological surgeries. The growing adoption of laparoscopy across specialties and its increasing procedure volume contribute to the significant share in the market.
Based on regions, the market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America has a high market share mainly due to a well-developed healthcare infrastructure along with a high demand for minimally invasive surgeries. The United States is a major market as it is predominantly affected by chronic diseases, increasing the aging population, and adoption of laparoscopic procedures on a larger scale. Innovations in device technology and strong healthcare funding further support the growth in the region.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Fujifilm Corporation is a Japan-based company that was founded in 1934. The company is a leading player in the market. Its portfolio includes advanced products such as its Insufflator Pump, which is used in minimally invasive surgeries. This device controls the flow of gas during procedures such as laparoscopy, thus, making the surgery safer and more effective.
Medtronic is a global leader in medical technology, founded in 1949 and headquartered in Dublin, Ireland. The company offers Covidien insufflation needles, designed for safe and efficient gas delivery during minimally invasive surgeries. These devices play a key role in enhancing precision and safety in laparoscopic procedures, driving market growth.
Stryker Corporation is one of the leading companies in the market. It was founded in 1941, and headquartered in Kalamazoo, Michigan. The company provides a variety of advanced insufflation products, such as its popular Stryker Insufflator, designed for optimal carbon dioxide delivery during minimally invasive surgeries. It continues to innovate, enhancing surgical precision and patient safety.
Olympus Corporation, founded in 1919 and located in Tokyo, Japan, is one of the largest insufflation devices manufacturers in the globe. The company is renowned for producing advanced medical technologies, such as the Olympus UHI-4 Intra-Abdominal Insufflation Unit. With the rising insufflation devices demand in the medical industry, it aims to provide accurate and secure minimally invasive surgical procedures.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Becton, Dickinson and Company, B. Braun Melsungen AG, Smith & Nephew plc, KARL STORZ SE & Co. KG, Steris plc, CONMED Corporation, and Richard Wolf GmbH.
Upto 15% Off
USD
$5499 $4949
$3299 $2969
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share